Among the class 3 semaphorins, SEMA3C is notable for its frequent association with tumor progression and poor prognosis across multiple tumor types including lung, breast, gastric, and ovarian cancers as well as glioblastoma (Rehman & Tamagnone, 2013). This evidence concerns the gene SEMA3C and glioblastoma.